Peter J. Campbell

Wellcome Genome Campus - Cancer Genome Project

Hinxton, Saffron Walden

Cambridge, England CB10 1SA

United Kingdom

Wellcome Trust Sanger Institute

Hinxton, Saffron Walden

Cambridge, England CB10 1SA

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

130

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Undifferentiated Sarcomas Develop Through Distinct Evolutionary Pathways

Number of pages: 54 Posted: 02 Jul 2018
University College London, Francis Crick Institute - Cancer Genomics Laboratory, Government of the United States of America - Theoretical Biology and Biophysics, University College London - Research Department of Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, Francis Crick Institute - Cancer Genomics Laboratory, University College London - Research Department of Pathology, Wellcome Sanger Institute, Wellcome Genome Campus - Cancer Genome Project, Wellcome Genome Campus - Cancer Genome Project, University College London - Research Department of Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, University College London - Research Department of Pathology, Wellcome Genome Campus - Cancer Genome Project, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust - Department of Cellular and Molecular Pathology, Wellcome Genome Campus - Cancer Genome Project, Francis Crick Institute - Cancer Genomics Laboratory, University College London - Research Department of Pathology and University College London - Research Department of Pathology
Downloads 51 (417,889)

Abstract:

Loading...

2.

Timing the Initiation of Multiple Myeloma

Number of pages: 122 Posted: 25 Jun 2019
Memorial Sloan Kettering Cancer Center - Myeloma Service, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Wellcome Sanger Institute, Institut D’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Essex, Wellcome Sanger Institute, Wellcome Sanger Institute, Wellcome Sanger Institute, University of Milan, Faculty of Medicine, Oncology and Hemato-Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori - Division of Hematology and Bone Marrow Transplantation, University of Milan, Harvard University - Dana-Farber Cancer Institute, University of Nantes, Memorial Sloan Kettering Cancer Center - Myeloma Service, University of California, San Diego (UCSD) - Moores Cancer Center, University of Barcelona, Patologia Molecular de Neoplàsies Limfoides, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Ulm, IUC-Oncopole, Memorial Sloan Kettering Cancer Center - Myeloma Service, Harvard University - Dana-Farber Cancer Institute, Wellcome Genome Campus - Cancer Genome Project and Memorial Sloan Kettering Cancer Center - Myeloma Service
Downloads 42 (452,325)
Citation 2

Abstract:

Loading...

Multiple Myeloma, Mutational Signatures, Molecular Time, Cancer Initiation, Germinal Center

3.

Sequential Inverse Dysregulation of the RNA Helicases DDX3X and DDX3Y Facilitates MYC-Driven Lymphomagenesis

Number of pages: 68 Posted: 21 Jan 2020
Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, Singapore General Hospital - Department of Haematology, The Babraham Institute, Wellcome Trust and MRC Cambridge Stem Cell Institute, University of Cambridge - Division of Cellular and Molecular Pathology, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, University of York - Epidemiology and Cancer Statistics Group, Singapore General Hospital - Department of Haematology, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, Wellcome Trust and MRC Cambridge Stem Cell Institute, Francis Crick Institute, Nanyang Technological University (NTU) - School of Biological Sciences, Teesside University - School of Health & Life Sciences, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - Division of Cellular and Molecular Pathology, Singapore General Hospital - Department of Clinical Translational Research, Addenbrooke’s Hospital - Department of Paediatric Oncology, Nanyang Technological University (NTU) - School of Biological Sciences, Wellcome Trust Sanger Institute, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Wellcome Genome Campus - Cancer Genome Project, Teesside University - School of Health & Life Sciences, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - MRC Laboratory of Molecular Biology, University of York - Epidemiology and Cancer Statistics Group, St. James’s Institute of Oncology - Haematological Malignancy Diagnostic Service, Goethe University Frankfurt - Department of Medicine II, Hematology/Oncology, The Babraham Institute, University of Cambridge - Division of Cellular and Molecular Pathology, University of Cambridge - MRC Cancer Unit and Wellcome Trust and MRC Cambridge Stem Cell Institute
Downloads 37 (473,788)

Abstract:

Loading...

Lymphoma, Translation, Cancer, MYCDDX3X